Duodopa Critical Aspects of PEG-J Preparation Placement and Aftercare
The information presented in these slides is provided as part of additional Risk Minimisation Program for Duodopa targeted to minimise:
–Gastrointestinal (GI) events
–Device-related risks
–Procedure-related risks associated with the levodopa – carbidopa intestinal gel (LCIG) system